We offer diverse tools for all your gene editing needs. Our next-generation platform enables genetic materials to be removed, added, or altered at a specific location. Explore how we’re advancing life-changing therapies here: https://lnkd.in/eY-aVETK. #GeneEditing #GeneTherapies
Life Edit Therapeutics
生物技术
Durham，North Carolina 7,449 位关注者
A next-generation gene editing company
关于我们
Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies.
- 网站
-
https://lifeeditinc.com/
Life Edit Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- Durham，North Carolina
- 类型
- 私人持股
- 创立
- 2017
地点
-
主要
获取路线
300 Morris St
US，North Carolina，Durham，27701
Life Edit Therapeutics员工
动态
-
We’re pushing the boundaries of artificial intelligence, creating CRISPR models that can deliver on the promise of gene editing. Learn how Life Edit's using AI in a recent Elevated Insight: https://lnkd.in/eQ32-Pjv. #CRISPR #AI
-
-
Bronwyn Thornburg, Associate Director, Operations, shares what inspires her at Life Edit:
-
-
Reverse transcriptase (RT) editing allows for the most flexible and precise editing outcomes for different types of gene correction, insertion, or knock-out. The PAM diversity of our platform means we can position the nuclease as close to the editing site as possible, reducing the size of the required gRNA and enabling optimal editing of the target locus. Learn more: https://lnkd.in/eY-aVETK. #CRISPR #GeneEditing
-
-
We're attending the ASAP BioPharma Conference! Join Hélène Svahnqvist MBA for the Ask an Expert/Mentoring session on Nov 5 at 4:50pm. Register here: https://lnkd.in/eAAZDrTm #ASAPBioPharma #AllianceManagement #BioTech #ProfessionalDevelopment
-
-
We're thrilled to announce Amy Pooler as our SVP, Research and Development. Amy joins our team with over 20 years of scientific leadership and expertise with an extensive background in genetic medicine, drug development, and scientific strategy. Read the full press release here: https://lnkd.in/eAv6xPZH.
-
Our platform has broad therapeutic delivery capabilities, including viral and non-viral delivery platforms that provides flexibility in therapeutic design and application. Unlock new possibilities for a range of diseases and disorders with Life Edit - and take genome editing to the next level. Discover more about our platform at https://lnkd.in/eY-aVETK.
-
-
ICYMI: we gave our website a makeover! Explore our new site and take a behind-the-scenes look at our next-generation gene editing platform - lifeeditinc.com.
-
-
ElevateBio’s Michael Paglia, Chief Technology Officer, and Life Edit Therapeutics's Clare Murray, SVP, Corporate Development & Operations, participated at this year’s Cell & Gene Meeting on the Mesa. We’re proud to share our expertise and take part in shaping the future of medicine alongside industry leaders and peers. #MeetingOnTheMesa?#ElevateBio